Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Executive Chairman

Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. It is developing five proprietary products comprising I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma; Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. The company was founded in 2007 and is headquartered in Cranford, New Jersey.

Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care produ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2019-09-27	Premium	bought	Premium	Premium	Premium	President and CEO
2019-09-27	Premium	bought	Premium	Premium	Premium	Executive Chairman
2019-04-03	Premium	bought	Premium	Premium	Premium	President and CEO
2019-04-03	Premium	bought	Premium	Premium	Premium	Executive Chairman

CTXR - Citius Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CTXR